tetano
Editor, Senior Moderator
J Med Virol. 2020 Apr 14. doi: 10.1002/jmv.25876. [Epub ahead of print]
Defining Protective Epitopes for COVID-19 Vaccination Models.
Cimolai N[SUP]1[/SUP].
Author information
Abstract
Recent papers in the Journal provide tangible avenues for COVID-19 vaccine production as immunoreactive epitopes are brought to the forefront in these and many other emerging studies.[SUP]1,2[/SUP] The development of a consistent predictable animal model of COVID-19 infection is evidently also a welcome event for preliminary antiviral and vaccine assessments and surely brings us to another level of progression.[SUP]3[/SUP] This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.
KEYWORDS:
COVID-19; coronavirus; infection; pathology; pneumonia; vaccine
PMID:32285942DOI:10.1002/jmv.25876
Defining Protective Epitopes for COVID-19 Vaccination Models.
Cimolai N[SUP]1[/SUP].
Author information
Abstract
Recent papers in the Journal provide tangible avenues for COVID-19 vaccine production as immunoreactive epitopes are brought to the forefront in these and many other emerging studies.[SUP]1,2[/SUP] The development of a consistent predictable animal model of COVID-19 infection is evidently also a welcome event for preliminary antiviral and vaccine assessments and surely brings us to another level of progression.[SUP]3[/SUP] This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.
KEYWORDS:
COVID-19; coronavirus; infection; pathology; pneumonia; vaccine
PMID:32285942DOI:10.1002/jmv.25876